Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

6.500
-0.180-2.69%
Volume:1.54M
Turnover:9.99M
Market Cap:4.53B
PE:13.66
High:6.510
Open:6.500
Low:6.420
Close:6.680
52wk High:9.460
52wk Low:4.895
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:2.37
T/O Rate:0.79%
Dividend:0.28
Dividend Rate:4.36%
EPS(LYR):0.476
ROE:5.74%
ROA:2.99%
PB:0.77
PE(LYR):13.66
PS:0.46

Loading ...

Shandong Xinhua Pharmaceutical (00719) Cancels Total of 1.057 Million Granted but Unexercised Stock Options

Stock News
·
Jan 20

SHANDONG XINHUA (00719) Grants 6.9069 Million A-Shares Under 2021 Stock Option Incentive Plan

Stock News
·
Jan 14

SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Phloroglucinol Injection

Stock News
·
Dec 29, 2025

Xinhua Pharmaceutical Gets Registration Certificate for Influenza Drug in China

MT Newswires Live
·
Dec 23, 2025

AH Share Premium Rate and Deviation Rankings as of December 3

Stock News
·
Dec 03, 2025

AH Share Premium Rate Rankings as of December 1

Stock News
·
Dec 01, 2025

Shandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025

Bulletin Express
·
Dec 01, 2025

AH Share Premium Rate and Deviation Rankings as of November 28

Stock News
·
Nov 28, 2025

Xinhua Pharmaceutical Gets China Nod for Inflammatory Disease Drug-Related Marketing

MT Newswires Live
·
Nov 27, 2025

Xinhua Pharmaceutical's Dyspnea Drug Passes Chinese Regulator's Consistency Evaluation

MT Newswires Live
·
Nov 27, 2025

Xinhua Pharmaceutical (00719.HK / 000756.SZ) Announces Epinephrine Hydrochloride Injection Passes Generic Consistency Evaluation

Bulletin Express
·
Nov 27, 2025

Xinhua Pharmaceutical (00719.HK/000756.SZ) Receives Approval for Prednisolone Acetate

Bulletin Express
·
Nov 27, 2025

SHANDONG XINHUA (00719) Receives Approval Notice for Prednisolone Acetate API Marketing Application

Stock News
·
Nov 27, 2025

AH Premium Rate and Deviation Rankings as of November 26

Stock News
·
Nov 26, 2025

Xinhua Pharmaceutical Obtains Registration Certificate for Local Skin Anesthesia Drug

MT Newswires Live
·
Nov 25, 2025

HK Stock Movement | SHANDONG XINHUA (00719) Rises Over 4% as Lidocaine and Prilocaine Cream Gains Approval

Stock News
·
Nov 25, 2025

Here's Why Shandong Xinhua Pharmaceutical (HKG:719) Can Manage Its Debt Responsibly

Simply Wall St.
·
Nov 22, 2025

Xinhua Pharmaceutical (HKEx: 00719, SZSE: 000756) Gains Approval for Vonoprazan Fumarate API

Bulletin Express
·
Nov 17, 2025

SHANDONG XINHUA (00719) Receives Approval Notice for Vonoprazan Fumarate API Marketing Application

Stock News
·
Nov 17, 2025

Southbound Stock Connect Fund Flow (T+2) | Nov 17

Stock News
·
Nov 17, 2025